BeiGene Inventory 2014-2024 | ONC
BeiGene inventory from 2014 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
- BeiGene inventory for the quarter ending September 30, 2024 was $0.432B, a 36.21% increase year-over-year.
- BeiGene inventory for 2023 was $0.416B, a 47.38% increase from 2022.
- BeiGene inventory for 2022 was $0.282B, a 16.37% increase from 2021.
- BeiGene inventory for 2021 was $0.243B, a 171.72% increase from 2020.
BeiGene Annual Inventory
(Millions of US $) |
| 2023 |
$416 |
| 2022 |
$282 |
| 2021 |
$243 |
| 2020 |
$89 |
| 2019 |
$29 |
| 2018 |
$16 |
| 2017 |
$11 |
| 2016 |
$ |
| 2015 |
$ |
| 2014 |
$ |
| 2013 |
$ |
BeiGene Quarterly Inventory
(Millions of US $) |
| 2024-09-30 |
$432 |
| 2024-06-30 |
$443 |
| 2024-03-31 |
$447 |
| 2023-12-31 |
$416 |
| 2023-09-30 |
$317 |
| 2023-06-30 |
$321 |
| 2023-03-31 |
$297 |
| 2022-12-31 |
$282 |
| 2022-09-30 |
$291 |
| 2022-06-30 |
$262 |
| 2022-03-31 |
$246 |
| 2021-12-31 |
$243 |
| 2021-09-30 |
$151 |
| 2021-06-30 |
$118 |
| 2021-03-31 |
$73 |
| 2020-12-31 |
$89 |
| 2020-09-30 |
$36 |
| 2020-06-30 |
$33 |
| 2020-03-31 |
$29 |
| 2019-12-31 |
$29 |
| 2019-09-30 |
$38 |
| 2019-06-30 |
$49 |
| 2019-03-31 |
$13 |
| 2018-12-31 |
$16 |
| 2018-09-30 |
$20 |
| 2018-06-30 |
$6 |
| 2018-03-31 |
$7 |
| 2017-12-31 |
$11 |
| 2017-09-30 |
$6 |
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
|
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2013-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$17.962B |
$2.459B |
|
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
|
